Breast cancer
A study comparing a one week schedule of radiotherapy versus a three week schedule of radiotherapy given after surgery for breast cancer
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyPhase 3: compared with usual treatment
What it testsA medicine and radiation and surgery or a procedure
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Last updated on the registry 11 Nov 2024. Please confirm with the hospital that this trial is still taking patients.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Tata Medical CenterKolkata, West BengalDirections ↗
Registry summary (technical)
HYPOfractionated Radiation Therapy comparing a standard radiotherapy schedule (over three weeks) with a novel one week schedule in Adjuvant breast cancer: An open label randomised controlled study - HYPORT Adjuvant
Sponsor: Tata Medical Center
CTRI/2018/12/016816 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 11 Nov 2024 · read by us 5 Nov 2026